Regenerative Medical Technology (RMTG) Shares Outstanding (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Shares Outstanding (Entity) of $13.1 million for Q1 2026, up 4.79% year-over-year from $12.5 million in Q1 2025, and little changed quarter-over-quarter from $13.1 million in Q4 2025.
Regenerative Medical Technology (RMTG) Shares Outstanding (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $13.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 4.79% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $13.1 million (up 4.79% YoY), while the FY2025 annual figure was $13.1 million, up 4.79% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $13.1 million, roughly flat from $13.1 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $13.1 million in Q4 2025, with the low at $12.2 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $12.5 million (2023), against an average of $12.5 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) advanced 11.51% in 2022, then changed 0.0% in 2025.
- Regenerative Medical Technology's Shares Outstanding (Entity) stood at $12.4 million in 2022, then advanced by 0.4% to $12.5 million in 2023, then grew by 0.36% to $12.5 million in 2024, then climbed by 4.79% to $13.1 million in 2025, then changed by 0.0% to $13.1 million in 2026.
- Business Quant data shows RMTG's Shares Outstanding (Entity) at $13.1 million in Q1 2026, $13.1 million in Q4 2025, and $12.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 13.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.14 Mn |
| Dec 31, 2025 | 12.63 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Jun 30, 2025 | 12.54 Mn |
| Mar 31, 2025 | 12.54 Mn |
| Dec 31, 2024 | 12.53 Mn |
| Sep 30, 2024 | 12.54 Mn |
| Jun 30, 2024 | 12.49 Mn |
| Mar 31, 2024 | 12.49 Mn |
| Dec 31, 2023 | 12.45 Mn |
| Sep 30, 2023 | 12.44 Mn |
| Jun 30, 2023 | 12.44 Mn |
| Mar 31, 2023 | 12.44 Mn |
| Dec 31, 2022 | 12.22 Mn |
| Sep 30, 2022 | 12.25 Mn |
| Jun 30, 2022 | 12.22 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 11.48 Mn |
| Sep 30, 2021 | 12.03 Mn |
| Jun 30, 2021 | 10.93 Mn |